Category: Biologics
Global Biologics
-
Next Generation Complement Therapeutics Market, 2022-2035: Distribution by Target Disease Indication (Atypical Hemolytic Uremic Syndrome, Cardiac Transplantation Rejection, Cold Agglutinin Disease, COVID-19, Generalized Myasthenia Gravis, Guillain-Barre Syndrome, Hereditary Angioedema, Neuromyelitis Optica and Paroxysmal Nocturnal Hemoglobinuria), Therapeutic Area (Cardiovascular, Genetic, Hematological and Vascular, Infectious, Neurological and Neuromuscular Disorders), Type of Molecule (Biologic and Small Molecule), Target Pathway (Alternate, Classical, Lectin and Terminal Pathway), Type of Therapy (Monotherapy and Combination Therapy), Route of Administration (Intravenous, Oral and Subcutaneous), Key Geographical Regions (North America, Europe and Asia-Pacific): Industry Trends and Global Forecasts, 2022-2035
... Therapeutic Area (Cardiovascular, Genetic, Hematological and Vascular, Infectious, Neurological and Neuromuscular Disorders), Type of Molecule (Biologic and Small Molecule), Target Pathway (Alternate, Classical, Lectin and Terminal Pathway), Type of Therapy (Monotherapy and Combination Therapy), Route ... Read More
-
Global Combination Products Market, 2021-2027
... drug, device, and a biological product. The global combination products market is anticipated to reach valuation of ~USD 147,447 million by 2027, representing a CAGR of 7.1% from 2021 to 2027 as per the latest ... Read More
-
Drug Discovery Services Market by Process (Target Selection, Validation, Hit-to-lead), Type (Chemistry, Biology), Drug Type (Small molecules, biologics), Therapeutic Area (Oncology, Neurology) End User (Pharma, Biotech) - Global Forecast to 2026
... services market is projected to reach USD 31.4 billion by 2026 from USD 16.1 billion in 2021, at a CAGR of 14.3% during the forecast period of 2021 to 2026. Growing R&D expenditure in the ... Read More
-
Global Biopharmaceutical Logistics Market to 2027
... goods from one place to another. Temperature control, security, safety, regulatory compliance, and chain of custody are the interference for the biopharmaceutical manufacturers at every turn from the manufacturers to distributors. Global Biopharmaceutical Logistics Market ... Read More
-
Biologics Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery Including: 1) By Type: Monoclonal Antibodies (MAbs); Therapeutic Proteins; Vaccines 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others 3) By Route Of Administration: Oral; Parenteral; Others 4) By Drug Classification: Branded Drugs; Generic Drugs 5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs Covering: Merck & Co., Inc.; AbbVie Inc.; F. Hoffmann-La Roche AG; Johnson & Johnson; Pfizer Inc.
... market as it emerges from the COVID 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 48 geographies. Understand how the market is ... Read More
-
Global Biologics CDMO Market (2022 Edition) - Analysis By Type (Mammalian, Non-Mammalian), Product Type (Biologics, Biosimilars), By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2021-2026)
... research report, the global Biologics CDMO Market was valued at USD 9.9 Billion in the year 2020. Growth opportunities for the Biologics CDMO market is attributed to the growth of the geriatric population, rising technical ... Read More
-
Global Drug Discovery Market Size study, by Drug Type (Small Molecule Drugs and Biologic Drugs), by Technology (High Throughput Screening, Pharmacogenomics, Nanotechnology and Others), by End-User (Pharmaceutical Companies, Contract Research Organizations (CROs) and Others) and Regional Forecasts 2021-2027
... Regional Forecasts 2021-2027 Global Drug Discovery Market is valued at approximately at USD 53.85 Billion in 2020 and is anticipated to grow with a healthy growth rate of more than 8.3% over the forecast period ... Read More
-
Global Biopharmaceutical CMO And CRO Market Size study, by Source (Mammalian, Non-mammalian), By Service (Contract Manufacturing, Contract Research), By Product (Biologics, Biosimilars) and Regional Forecasts 2021-2027
... approximately USD 27.6 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 6.6 % over the forecast period 2021-2027. Biopharmaceutical CMO And CRO are contract manufacturing organizations and ... Read More
-
Global Bioreactors Market Size study, by Control Type (Manual, Automated (MFCs)), by Material (Glass, Stainless Steel, Single-Use), by End-Use (R&D Departments, R&D Institutes, CROs (Contract Research Organizations), Biopharmaceutical Companies, Biopharmaceutical Manufacturers, CMOs (Contract Manufacturing Organizations), Biopharmaceutical Companies) and Regional Forecasts 2021-2027
... Biopharmaceutical Companies) and Regional Forecasts 2021-2027 Global Bioreactors Market is valued at approximately USD 1410 million in 2020 and is anticipated to grow with a healthy growth rate of more than 6.00 % over the ... Read More
-
Biopharmaceutical CMO And CRO Market Size, Share & Trends Analysis Report By Source (Mammalian, Non-mammalian), By Service (Contract Manufacturing, Contract Research), By Product, And Segment Forecasts, 2022 - 2030
... to a new report by Grand View Research, Inc. Post-pandemic the market is being driven by the growing interest of conventional drug developers in the biological therapeutics. At present, outsourcing has become a cost-saving strategy ... Read More
-
Global Prefilled Syringe Market Research Report 2021
... at a CAGR of 2.6% during 2022-2027. This report focuses on Prefilled Syringe volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Prefilled Syringe ... Read More
-
Leukemia Therapeutics Market - By Leukemia Type (Acute Lymphocytic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), By Treatment Type (Targeted Drugs & Immunotherapy, Chemotherapy, By Molecule Type (Small Molecules, Biologics, By Mode Of Administration (Injectable, Oral) - Global Industry Perspective, Comprehensive Analysis And Forecast, 2021-2030
... Molecules, Biologics, By Mode Of Administration (Injectable, Oral) - Global Industry Perspective, Comprehensive Analysis And Forecast, 2021-2030 Market Overview Fatpos Global has released a report titled Leukemia Therapeutics Market - Analysis of Market Size, Share ... Read More
-
Pharmaceutical Sterility Testing Market - By Type (In-House And Outsourcing), By Test Type (Sterility Testing, Bioburden Testing, And Bacterial Endotoxin Testing), By Sample (Sterile Drugs, Medical Devices, And Biologics & Therapeutics), By End-Use (Compounding Pharmacies, Medical Devices Companies, And Pharmaceutical Companies), And By Region- Global Industry Perspective, Comprehensive Analysis, And Forecast, 2021 – 2030
... Medical Devices Companies, And Pharmaceutical Companies), And By Region- Global Industry Perspective, Comprehensive Analysis, And Forecast, 2021 – 2030 Market Overview Fatpos Global has released a report titled Pharmaceutical Sterility Testing Market - Analysis of ... Read More
-
Biopharmaceuticals Market by Product (Monoclonal Antibody, Interferon, Insulin, Growth and Coagulation Factor, Erythropoietin, Vaccine, Hormone, And Others) and by Application (Oncology, Blood Disorder, Metabolic Disease, Infectious Disease, Cardiovascular Disease, Neurological Disease, Immunology, And Others)- Global Opportunity Analysis and Industry Forecast 2022-2030
... Opportunity Analysis and Industry Forecast 2022-2030 The Biopharmaceuticals Market was valued at USD 345.84 billion in 2021 and is predicted to reach USD 974.48 billion by 2030 with a CAGR of 11.7% from 2022-2030. Biopharmaceutical ... Read More
-
Outsourcing in Drug Discovery, 9th Edition
... cost-cutting strategy that can also improve the hit-to-lead conversion and early identification of unsuccessful compounds. In view of the fact that outsourcing can accelerate the drug discovery process, the business of contract drug discovery has ... Read More
-
Global Biosimilars Market - Increasingly Lucrative Market Fueled by Constrained Payer Environment and Patent Expiries for Best-Selling Biologics
... Biologics Summary The Global Biosimilar market by product is projected to grow at a compound annual growth rate (CAGR) of 45.22%. The market is driven mainly by a constrained payer environment and patent expiration of ... Read More
-
World Market for Biopharmaceutical Drug Delivery Device Technology
... injections are not the first choice among patients and compliance is an ongoing issue. Further, as the majority of new entities in development are biologics requiring advanced drug delivery, manufacturers of devices have been busy ... Read More
-
Global Contract Biopharmaceuticals
... include commercial manufacturing and contract manufacturing. Major world regions include US, Western Europe, China, India, and all other regions. To illustrate historical trends, world, service, and regional demand are provided in annual series for 2012-2017. Read More
Research Assistance
